this is index.php

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

Publication date: 12/01/2015

Authors: Katherine O'Brien, Aruna Chandran, Robert Weatherholtz, Hasan Jafri, Ramel Griffin, Terramika Bellamy, Eugene Millar, Kathryn Jenson, Brian Harris, Raymond Reid, Lawrece Moulton, Genevieve Losonsky, Ruth Karron, Mathuram Santosham

Publication: the Lancet Infectious Diseases

Focus Area: Infectious Disease Prevention